formed was filtered off and washed several times with water and
toluene. Recrystallisation gave the appropriate 1,3-oxazolidin-
2-ones 16a–c.
stirred for 2 h at this temperature. Freshly distilled acid chloride
(1.1 equiv.) was added dropwise at Ϫ78 ЊC and the mixture
was stirred for 30 min and at room temperature for a further
24 h. The reaction mixture was poured into phosphate buffer
(0.01 M) and the organic phase was separated. The aqueous
layer was washed with DCM (×2) and the organic extracts were
combined and washed with aqueous saturated NaHCO3 and
brine. The organic phase was dried over MgSO4 and the solvent
removed in vacuo. Flash column chromatography afforded the
appropriate acylated 1,3-oxazolidin-2-ones.
Method B. Using triethylamine. To a suspension of the amino
alcohol (1 equiv.) in THF (0.2 M) cooled in an ice bath under
N2 was added triethylamine (2.2 equiv.) in one portion. A 0.35
M solution of triphosgene in THF (1.16 equiv.) was added
rapidly. The ice bath was removed and the slurry was aged
for 45 min at room temperature. The resultant white solid was
filtered and washed with THF and EtOAc. The filtrate was
dried over MgSO4 and the solvent removed in vacuo to give a
white solid. Column chromatography (EtOAc–hexane, 1 : 1)
and recrystallisation gave the desired compound.
Method D. Using triethylamine. To a solution or suspension
of the 1,3-oxazolidin-2-one (1 equiv.) in DCM (0.1–0.16 M) at
room temperature under N2 was added DMAP (0.2 equiv.) and
triethylamine (1.2 equiv.). Freshly distilled acid chloride (1.3
equiv.) was added dropwise over 5 min and the mixture was
stirred for 5 h at room temperature. The reaction mixture was
quenched into saturated aqueous NH4Cl and the organic phase
was separated. The aqueous layer was washed with DCM (×3)
and the organic extracts were combined, washed with aqueous
saturated NaHCO3 and brine, dried over MgSO4 and the
solvent removed in vacuo. Purification via flash column chrom-
atography afforded the requisite acylated 1,3-oxazolidin-2-ones.
(S)-5,5-Diphenyl-4-isopropyl-3-(1Ј-oxopropyl)-1,3-oxazol-
idin-2-one 21a. Using method C with (S)-5,5-diphenyl-4-
isopropyl-1,3-oxazolidin-2-one 16a (0.563 g, 2.00 mmol) and
propionyl chloride (0.2 cm3, 2.3 mmol) followed by flash
column chromatography eluting with DCM–hexane (6 : 4)
furnished the title compound 21a as a white solid (0.471 g,
1.4 mmol, 70%), mp 110–113 ЊC (lit.15 111–112 ЊC) (Found: C,
74.83; H, 7.06; N, 4.04; MHϩ 338.1749. Calculated for
C21H23NO3: C, 74.75; H, 6.87; N, 4.15%: 338.1756.); [α]D
Ϫ258.3 (c = 1.04, CHCl3) (lit.15 [α]D Ϫ239.7 (c = 0.74, CHCl3));
νmax (KBr) 1772 (s, C᎐O), 1708 (s, C᎐O) cmϪ1; δH (CDCl3) 7.49–
(S)-5,5-Diphenyl-4-isopropyl-1,3-oxazolidin-2-one
16a.
Using method A with (S)-2-amino-1,1-diphenyl-3-methyl-
butan-1-ol 19a (3.945 g, 15.47 mmol) afforded the title com-
pound as white needle-like crystals (3.176 g, 11.3 mmol, 73%)
(EtOH–H2O), mp 247–250 ЊC (lit.13 253.2–253.9 ЊC) (Found: C,
76.73; H, 6.85; N, 4.87: MHϩ 282.1400. Calculated for
C18H19NO2: C, 76.84; H, 6.81; N, 4.98%: 282.1494); [α]D Ϫ263.4
(c = 0.51, CHCl3) (lit.13 [α]D Ϫ253.1 (c = 0.1, CHCl3)); νmax
(KBr) 3292 (m, N–H), 1764, 1745 (s, C᎐O) cmϪ1; δH (d6-DMSO)
᎐
8.13 (s, 1H, ϪNH), 7.68–7.21 (m, 6H, aryl-H), 4.38 (s, 1H,
HN–H), 1.83 (m, 1H, –CH(CH3)2), 0.90 (d, 3H, J 6.8, –CH3),
0.52 (d, 3H, J 6.8, –CH ); δ (d -DMSO) 157.33 (C᎐O), 145.36,
᎐
3
C
6
139.80, 128.37, 128.06, 127.68, 127.19, 125.51, 125.09 (aryl-C),
87.65 (C-β), 64.19 (C-α), 29.06 (CH(CH3)2), 16.60, 14.50
(–CH3).
(S)-5,5-Di(2Ј-naphthyl)-4-isopropyl-1,3-oxazolidin-2-one
16b. Using method A with (S)-2-amino-1,1-di(2Ј-naphthyl)-3-
methylbutan-1-ol 19b (2.483 g, 6.99 mmol) gave the title com-
pound as white needles (1.581 g, 4.15 mmol, 59%) (toluene), mp
240–242 ЊC (Found: C, 81.65; H, 5.78; N, 3.37: MHϩ 382.1818.
C26H23NO2 requires: C, 81.86; H, 6.08; N, 3.67%: 382.1807);
[α]D Ϫ373.6 (c = 0.06, CHCl3); νmax (KBr) 3285 (br, N–H), 1754,
᎐
᎐
7.25 (m, 10H, aryl-H), 5.38 (d, 1H, J 3.5, –NCH), 2.93 (dq, 1H,
J 17.3 and 7.3, –CHAHCH3), 2.73 (dq, 1H, J 17.3 and 7.3,
–CHHBCH3), 1.98 (m, 1H, –CH(CH3)2), 1.09 (t, 3H, J 7.3,
–CHAHBCH3), 0.88 (d, 3H, J 7.0, –CH3), 0.76 (d, 3H, J 6.5,
1706 (s, C᎐O) cmϪ1; δH (CDCl3) 8.09–7.16 (m, 14H, aryl-H),
᎐
6.62 (s, 1H, –CHNH), 4.63 (d, 1H, J 2.9, HNCH), 1.93 (m,
1H, –CH(CH3)2), 0.97 (d, 3H, J 6.8, –CH3), 0.75 (d, 3H, J 6.8,
–CH3); δC (CDCl ) 174.19 (C(᎐O)CH CH ), 153.28 (C᎐O),
᎐
᎐
3
2
3
142.57, 138.43, 129.09, 128.77, 128.57, 128.13, 126.14, 125.83
(aryl-C), 89.56 (C-β), 64.60 (C-α), 30.11 (–CH2CH3), 29.10
(–CH(CH3)2), 22.00, 16.57 (–CH3), 8.85 (–CH2CH3).
–CH3); δC (CDCl ) 158.97 (C᎐O), 136.59, 133.17, 132.98,
᎐
3
132.97, 132.75, 128.80, 128.69, 128.63, 128.02, 127.75, 127.71,
126.86, 126.77, 126.77, 126.73, 126.69, 125.52, 124.80, 124.59,
124.52, 124.40 (aryl-C), 89.99 (C-β), 65.43 (C-α), 29.96
(–CH(CH3)2), 21.25, 15.90 (–CH3).
(S)-5,5-Di(2Ј-naphthyl)-4-isopropyl-3-(1Љ-oxopropyl)-1,3-
oxazolidin-2-one 21b. Using method C with (S)-5,5-di(2Ј-
naphthyl)-4-isopropyl-1,3-oxazolidin-2-one 16b (0.258 g, 0.69
mmol) and propionyl chloride (0.07 cm3, 0.81 mmol) followed
by flash column chromatography using DCM–hexane (9 : 1) as
the eluant furnished the desired product as a white crystalline
solid (0.265 g, 0.62 mmol, 90%), mp 145–147 ЊC (EtOH)
(Found: C, 79.90; H, 6.13; N, 3.19: MHϩ 438.2109. C29H27NO3
requires: C, 79.61; H, 6.22; N, 3.21%: 438.2069); [α]D Ϫ385.2
(S)-5,5-Di(4Ј-tolyl)-4-isopropyl-1,3-oxazolidin-2-one
16c.
Using method A with (S)-2-amino-1,1-di(4Ј-tolyl)-3-methyl-
butanol 19c (2.000 g, 7.07 mmol) gave the title compound as
colourless needles (1.182 g, 3.83 mmol, 54%) (EtOH), mp 186–
188 ЊC (Found: C, 77.45; H, 7.53; N, 4.55: MHϩ 310.1829.
C20H23NO2 requires: C, 77.64; H, 7.48; N, 4.53%: 310.1807);
[α]D Ϫ235.7 (c = 1.03, CHCl3); νmax (KBr) 3264 (br, N–H), 1749,
1717 (s, C᎐O) cmϪ1; δH (CDCl3) 7.44–7.09 (m, 8H, aryl-H), 6.52
(c = 1.02, CHCl3); νmax (KBr) 1770 (s, C᎐O), 1713 (s, C᎐O)
᎐
᎐
᎐
cmϪ1; δH (CD2Cl2) 7.80–6.94 (m, 14H, aryl-H), 5.31 (d, 1H,
J 3.0, –NCH), 2.55 (dq, 1H, J 17.4 and 7.3, –CHAHCH3),
2.32 (dq, 1H, J 17.4 and 7.3, –CHHBCH3), 1.66 (m, 1H,
–CH(CH3)2), 0.68 (t, 3H, J 7.3 –CH2CH3), 0.56 (d, 3H, J 6.8,
–CH3), 0.42 (d, 3H, J 6.8, –CH3); δC (CD2Cl2) 174.33
(s, 1H, –CHNH), 4.32 (d, 1H, J 3.2, –CHNH), 2.32 (s, 6H,
PhCH3), 1.83 (m, 1H, –CH(CH3)2), 0.89 (d, 3H, J 6.8, –CH3),
0.71 (d, 3H, J 6.8, –CH3); δC (CDCl ) 159.00 (C᎐O), 141.40,
᎐
3
138.09, 137.50, 136.67, 129.33, 128.89, 126.47, 125.83 (aryl-C),
89.64 (C-β), 66.06 (C-α), 29.81 (–CH(CH3)2), 21.23, 21.06
(PhCH3), 15.97 (–CH3).
Using method B with (S)-2-amino-1,1-di(4Ј-tolyl)-3-methyl-
butanol 19c (0.255 g, 0.90 mmol) the title compound was
obtained as fine, white needle-like crystals (0.171 g, 0.56 mmol,
62%) (EtOH–H2O) with identical spectroscopic data to those
reported above.
(–(C᎐O)CH CH ), 153.51 (C᎐O), 139.92, 136.05, 133.59,
᎐
᎐
2
3
133.41, 133.18, 129.54, 129.11, 128.89, 128.78, 128.13, 127.99,
127.52, 127.31, 127.25, 125.22, 125.01, 124.55, 124.32 (aryl-C),
90.11 (C-β), 64.37 (C-α), 30.82 (–CH2CH3), 29.16 (CH(CH3)2),
22.31, 16.62 (–CH3), 8.97 (–CH2CH3).
(S)-5,5-Di(4Ј-tolyl)-4-isopropyl-3-(1Љ-oxopropyl)-1,3-
oxazolidin-2-one 21c. Using method C with (S)-5,5-di(4Ј-tolyl)-
4-isopropyl-1,3-oxazolidin-2-one 16c (0.250 g, 0.81 mmol) and
propionyl chloride (0.08 cm3 0.92 mmol) followed by flash
column chromatography using hexane–EtOAc (3 : 1) as the elu-
ant furnished the title compound as a colourless solid (0.288 g,
0.79 mmol, 98%), mp 58.5–60.5 ЊC (Found: C, 75.54; H, 7.63;
N, 3.74: MHϩ 366.2042. C27H27NO3 requires: C, 75.59; H, 7.45;
General procedures for the acylation of the 1,3-oxazolidin-2-ones
Method C. Using n-butyllithium. To a solution or suspension
of the 1,3-oxazolidin-2-one (1 equiv.) in THF (0.07–0.1 M) at
Ϫ78 ЊC under N2 was added n-butyllithium (1.6 M in hexane,
1.04 equiv.) portionwise over 10 min and the mixture was
1544
J. Chem. Soc., Perkin Trans. 1, 2001, 1538–1549